摘要
目的探讨ⅢA.N2期非小细胞肺癌(NSCLC)患者根治术后肿瘤的复发情况及其相关影响因素。方法回顾北京大学第一医院2004年9月至2008年12月期间行肺癌根治术,并经病理证实为ⅢA,N2期的63例NSCLC患者的临床资料,随访监测肿瘤复发情况,Kaplan—Meier法计算术后复发率,应用Cox比例风险回归模型分析复发影响因素。结果63例患者术后2年和3年复发率分别为46.6%和57.3%,其中主要以转移性复发为主(27/28),局部复发仅1例;Cox单因素回归分析表明肿瘤组织中有淋巴血管侵犯(LVl)术后复发风险是LVI阴性者的2.54倍;N2阳性淋巴结数量〉3者的复发风险是淋巴结数1~3者的2.48倍;N2多站淋巴结转移者术后复发是N2单站淋巴结转移者的3.34倍;隆突下淋巴结转移者术后复发风险是未转移者的2.11倍。结论ⅢA—N2期NSCLC患者主要以转移性复发为主,影响术后复发的重要危险因素包括Lvl、N2阳性淋巴结站数、N2阳性淋巴结数量和隆突下淋巴结是否转移。
Objective To explore the postoperative recurrence patterns in the patients undergoing potentially curative resection of stage Ⅲ A-N2 non-small cell lung cancer (NSCLC). Methods A total of 63 patients underwent curative operation from September 2004 to December 2008 at Peking University First Hospital and were pathologically diagnosed as stage ⅢA-N2 NSCLC. Their clinical data were retrospectively reviewed. The follow-ups were conducted to detect the recurrent lesions. The recurrence rates at Year 2 -3 were calculated by the Kaplan-Meier method while the Cox proportional hazard model was used to assess the risk factors associated with recurrence. Results The 2 and 3-year recurrence rate was 46. 6% and 57. 3% respectively. Only one patient experienced local failure. However, the predominant recurrence pattern was distant failure (27/28). As demonstrated by the univariate Cox regression analysis, 4 significant factors associated with recurrence and the arm of lymphatic or vascular invasion ( LVI ) , number of positive N2 station 〉 1, number of positive node 〉 3 and involvement of subcarinal lymph nodes were found to increase the risks of failure ( P 〈 0. 05 ). Conclusion Distant failure is the predominant pattern of postoperative recurrence in the patients of stage ⅢA-N2 NSCLC. In addition to LVI, the level of positive N2 station, the number of positive N2 node and the involvement of subcarinal lymph nodes are associated with the postoperative risk of recurrence.
出处
《中华医学杂志》
CAS
CSCD
北大核心
2012年第33期2314-2318,共5页
National Medical Journal of China
关键词
癌
非小细胞肺
纵隔
复发
Carcinoma, non-small-cell lung
Mediastinum
Recurrence